J9355 Trastuzumab - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Trastuzumab

Brand Name:

Herceptin

Strength:

10 mg

HCPCS:

J9355

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Monoclonal Antibody

Minor Drug Class:

HER2

Oral (Y/N):

No

FDA Approval Year:

1998

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2000

CMS Discontinuation Date:

Status:

In Use